March 25, 2011
FOR IMMEDIATE RELEASE
Pancreatic Cancer Action Network and AACR Award Research Grants Totaling Nearly $3 Million
ORLANDO, Fla. – - The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded ten grants to outstanding scientists throughout the country, supporting their innovative research in the field of pancreatic cancer. This year’s total funding level of nearly $3 million represents the largest annual disbursement since the Pancreatic Cancer Action Network introduced the program in 2003. The recipients will be honored at a recognition event scheduled during the AACR 102nd Annual Meeting 2011, held April 2-6, at the Orange County Convention Center, Orlando, Fla.
"These grants are crucial to promoting ongoing impactful pancreatic cancer research," said Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association for Cancer Research. "They encourage both young and experienced researchers to collaborate in an effort to make innovative breakthroughs to beat this devastating disease."
"This year’s grants program marks a significant milestone – over $10 million in research funding awarded by the Pancreatic Cancer Action Network since our program’s inception eight years ago," stated Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. "As we work to double the survival rate for pancreatic cancer by 2020, we are committed to building a comprehensive and coordinated pancreatic cancer research community to speed the acquisition of knowledge, share information and move findings into practice. We look forward to partnering with this talented group of new grant recipients."
The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants are five-year grants totaling $600,000 each. These grants are designed to support the future leadership of pancreatic cancer research by funding outstanding early-career investigators beginning in their postdoctoral, mentored research positions and continuing through their successful transition to independence. The 2011 recipients are:
The Pancreatic Cancer Action Network-AACR Innovative Grants are intended to promote the development and study of novel ideas and approaches in basic, translational, clinical or epidemiological research that have direct application and relevance to pancreatic cancer. These two-year grants provide $200,000 over the grant term. The 2011 recipients are:
- Jennifer M. Bailey, Ph.D., Johns Hopkins University School of Medicine: "Stop the Start: Novel Insights into PanIN Initiation and Progression."
- E. Scott Seeley, M.D., Ph.D., Stanford University: "Transport Proteins as Modifiers of Oncogenic Signaling in Pancreatic Cancer."
The Pancreatic Cancer Action Network-AACR Career Development Awards are two-year grants of $200,000 that are designed to attract and support early-career scientists as they conduct pancreatic cancer research and establish successful career paths in the field. The 2011 recipients are:
- Lisa A. Cannon-Albright, Ph.D., University of Utah: "Informative Linkage Analysis of High-Risk Pancreatic Cancer Pedigrees."
- James R. Eshleman, M.D., Ph.D., Johns Hopkins University School of Medicine: "Identifying Familial Pancreatic Cancer Predisposition Genes."
- Matthias Hebrok, Ph.D., University of California, San Francisco: "Role of miRNAs in Pancreatic Adenocarcinoma." (Grant in memory of Abby Sobrato.)
- Hidde L. Ploegh, Ph.D., Whitehead Institute for Biomedical Research: "Generation of Transnuclear Mice from Pancreatic Cancer Infiltrating T Cells." (Grant in honor of the Kovler Family.)
The Pancreatic Cancer Action Network-AACR Fellowship is a one-year grant of $45,000 designed to support a postdoctoral investigator’s work in pancreatic cancer research. The 2011 recipient is:
- Dimitrios Iliopoulos, Ph.D., Dana-Farber Cancer Institute: "Identification of Novel Molecular Circuits in Pancreatic Cancer Stem Cells."
- Kenneth P. Olive, Ph.D., Columbia University Medical Center: "The Role of HIF1 and Hypoxia in Pancreatic Ductal Adenocarcinoma." (Grant in honor of Tempur-Pedic Retailers.)
- Jae-Il Park, Ph.D., The University of Texas MD Anderson Cancer Center: "Telomerase in the Development of Pancreatic Cancer."
In its mission to advance pancreatic cancer research, the Pancreatic Cancer Action Network has collaborated with the AACR to promote and support outstanding research focused on conquering this deadly disease. The goals of the grants program are to build a robust pancreatic cancer research community, to encourage collaboration, information-sharing and innovation, and to expedite scientific and medical breakthroughs for patient benefit.
- Cosimo Commisso, Ph.D., New York University School of Medicine: "Pancreatic Cancer, Macropinocytosis and Nutrient Internalization." (Fellowship in memory of Samuel Stroum.)
To learn more about the Pancreatic Cancer Action Network, visit www.pancan.org.
About the American Association for Cancer Research
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative–The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.
MEDIA INQUIRIES ONLY CONTACT:
Senior Manager, Public Relations
Pancreatic Cancer Action Network
ALL OTHER INQUIRIES, PLEASE CALL THE PANCREATIC CANCER ACTION NETWORK AT 877-272-6226 OR EMAIL INFO@PANCAN.ORG.